Built from Innovative Eyewear, Inc.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
LUCY · Nasdaq · Healthcare · Medical Instruments and Supplies
$0.84-1.0%Nov 11 close
Figures through September 30, 2026, from the 10-Q filed November 9, 2026
The themes Innovative Eyewear is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
ISRGIntuitive Surgical, Inc.$155.8BA+
MDLNMedline Inc.$55.5BA
ALCAlcon Inc.$35.3BA
BLCOBausch & Lomb Corp$7.6BA-
ATRCAtriCure, Inc.$2.9BARose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher CorporationOct 21, 2026CBGraded C, now B
MCKMckesson CorporationNov 4, 2026BAGraded B, now A
CVSCVS Health CorpNov 4, 2026BAGraded B, now A
EWEdwards Lifesciences CorporationNov 4, 2026BAGraded B, now A
BIIBBiogen Inc.Oct 28, 2026BAGraded B, now AGrade F-
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 15 quarters of Innovative Eyewear, Inc.’s grade history. The other 13 go back to May 2023.